Studies that include patients who are considered at-risk (i.e., diabetics, cardiac, elderly, etc.) and are currently taking GLP-1 RAs should also be performed as these patients may have compounding risk during the perioperative period which may make them more susceptible to complications related to GLP-1 use (Santos et al
Compounding is explicitly permitted under federal law (sections 503A and 503B of the Food, Drug & Cosmetic Act) under specific conditions
Compounds like BPC-157, TB-500, GHK-Cu, Semaglutide, Tesamorelin, and CJC-1295 are commonly included in research protocols
Glucose-dependent insulinotropic polypeptide
Blanco encontrar el adecuado para cada paciente
Photodamage, Texture, and Surface Topography Multi-week topical studies in photodamaged skin models reported improvements in laxity, clarity, and firmness metrics, with concurrent reductions in fine-line and coarse-wrinkle measures